Dual agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | 39-residue synthetic peptide |
| Average molecular mass | About 4813.5 Da | Free base form |
| Appearance | White to off-white powder | Solid after lyophilization |
| Solubility class | Freely soluble in water | Also soluble in neutral aqueous buffers |
| Typical storage | At or below -20 °C, desiccated | Protect from light and moisture |
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
== Medical uses == Velmanase alfa is indicated for the treatment of the non-central nervous system manifestations of alpha-mannosidosis. Alpha-mannosidosis is a rare genetic lysosomal storage disorder. The symptoms of the disorder vary, but often include mild to moderate intellectual disability, hearing loss, weakened immune system, distinctive facial features (e.g., a large head, prominent forehead, and protruding jaw), skeletal abnormalities, and muscle weakness. Alpha-mannosidosis is caused by genetic changes in the MAN2B1 gene, which codes for the lysosomal alpha-mannosidase enzyme. Mutations of the MAN2B1 gene result in the lack of production of the alpha-D-mannosidase enzyme or the production of a defective, inactive form of the enzyme. Alpha-mannosidosis affects about 1 in every 500,000 people worldwide.
==== 5-HT system in vertebrates ==== Vertebrates are multicellular organisms in the phylum Chordata that possess a backbone and a nervous system. This includes mammals, fish, reptiles, birds, etc. In humans, the nervous system is composed of the central and peripheral nervous system, with little known about the specific mechanisms of neurotransmitters in most other vertebrates. However, it is known that while serotonin is involved in stress and behavioral responses, it is also important in cognitive functions. Brain organization in most vertebrates includes 5-HT cells in the hindbrain. In addition to this, 5-HT is often found in other sections of the brain in non-placental vertebrates, including the basal forebrain and pretectum. Since location of serotonin receptors contribute to behavioral responses, this suggests serotonin is part of specific pathways in non-placental vertebrates that are not present in amniotic organisms. Teleost fish and mice are organisms most often used to study the connection between serotonin and vertebrate behavior. Both organisms show similarities in the effect of serotonin on behavior, but differ in the mechanism in which the responses occur.
===== Automated handover to laboratories and pharmacies ===== Some PTS installations provide automated interfaces to pre-analytical laboratory lines, allowing carriers to be received, identified, and unloaded robotically so that standard tests enter fully automated tracks with minimal manual handling. Pharmacies likewise integrate stations that enforce controlled access and electronic logging at dispatch and receipt.
"Cheese" is a heroin-based recreational drug that came to the attention of the media inside and outside the United States after a string of deaths among adolescents in Dallas, between 2005 and 2007. As of 2012 the drug use was now among older people who were teenagers around the period the drug was first discovered. Cheese is a combination of drugs, made by combining heroin with crushed tablets of certain over-the-counter cold medication, such as Tylenol PM. Such cold medications contain acetaminophen (paracetamol), the active ingredient in Tylenol, and the antihistamine diphenhydramine, the active ingredient in Benadryl. Cheese samples obtained in north Dallas contained between 2% and 8% heroin, in contrast to the 30% commonly found in black tar heroin. Users commonly take the powder by insufflation ("snorting") rather than by intravenous injection. This mixture is also known as "Tylenol With Smack", by analogy to the Tylenol With Codeine series. Due to the high concentrations of non-opiate substances relative to the diamorphine content of the drug, abuse and overdose of cheese are more dangerous than pure-form opiate overdoses. Emergency personnel must address the overdose effects of each component of the drug, since the contents and concentrations of each component vary widely among batches they must wait for either the completion of the toxicology report to begin treatment or wait for the effects of each drugs overdose to manifest. The acetaminophen content of the drug induces severe, irreversible damage to the liver when taken in high doses for long periods of time.
Sources: en.wikipedia.org
=== Foaming power === Many types of cake requires trapping air in a matrix of beaten eggs (mainly the proteins in egg white) for its foamy texture. Drying eggs with heat reduces the ability of the reconstituted mixture to produce foam, but powdered eggs with reduced yolk content and a little sodium lauryl sulfate can produce foam as light as fresh whole eggs. (Yolk and other oils reduce the foaming ability of egg mixtures, whether fresh or reconstituted.) With pure egg whites, freeze-drying retains much more foaming power than conventional spray-drying. A lower spray-drying temperature is associated with better preservation of foaming power.
Very hot objects emit UV radiation (see black-body radiation). The Sun emits ultraviolet radiation at all wavelengths, including the extreme ultraviolet where it crosses into X-rays at 10 nm. Extremely hot stars (such as O- and B-type) emit proportionally more UV radiation than the Sun. Sunlight in space at the top of Earth's atmosphere (see solar constant) is composed of about 50% infrared light, 40% visible light, and 10% ultraviolet light, for a total intensity of about 1400 W/m2 in vacuum. The atmosphere blocks about 77% of the Sun's UV, when the Sun is highest in the sky (at zenith), with absorption increasing at shorter UV wavelengths. At ground level with the sun at zenith, sunlight is 44% visible light, 3% ultraviolet, and the remainder infrared. Of the ultraviolet radiation that reaches the Earth's surface, more than 95% is the longer wavelengths of UVA, with the small remainder UVB. Almost no UVC reaches the Earth's surface. The fraction of UVA and UVB which remains in UV radiation after passing through the atmosphere is heavily dependent on cloud cover and atmospheric conditions. On "partly cloudy" days, patches of blue sky showing between clouds are also sources of (scattered) UVA and UVB, which are produced by Rayleigh scattering in the same way as the visible blue light from those parts of the sky. UVB also plays a major role in plant development, as it affects most of the plant hormones.
In 2024, D'Souza criticized the International Olympic Committee (IOC), alleging institutional corruption and inadequate athlete compensation. He also advocated for the abolition of the World Anti-Doping Agency (WADA), characterizing it as an "anti-science" extension of the IOC. D'Souza also argued that the Olympic program includes insignificant sports. He states that he has never used performance-enhancing drugs himself. By late 2025, he had been replaced as chief executive by Maximilian Martin, investment banker and bitcoin miner. Olympians attached to the organisation as of 2023 include Brett Fraser, Roland Schoeman, and Christina Smith. In 2025, Brett Hawke was named head swim coach. Other people include geneticist George Church. German biotech billionaire Christian Angermayer is co-founder of the organisation. D'Souza became Thiel's confidant in the process of leading the Gawker plan for him, and through Thiel's introduction, a friend of Angermayer. According to The Spectator, in December 2022, as D'Souza and other members of their small community of gay tech founders were about to gather for the annual party at Thiel's residence in Miami (formerly held while travelling the world, until Thiel had children), D'Souza came up with the idea of the Enhanced Games. After receiving positive feedback from Thiel (while other investors thought that the idea was "outside the Overton window"), D'Souza spent the next six months developing the project. Later, after reading about the plan on German media, Angermayer notified D'Souza that he wanted to come on board as a co-founder.
== External links == http://www.apsciences.com http://www.invitroadmet.com "Scientist shows the way to take guinea pigs off lab," Karthika Gopalakrishnan. The Times of India. 17 February 2011. Retrieved 19 August 2015.
This peptide contains two adjacent tryptophan residues, which is unusual, since tryptophan is a fairly uncommon amino acid (about one in a hundred residues in a typical E. coli protein is tryptophan). If the ribosome attempts to translate this peptide while tryptophan levels in the cell are low, it will stall at either of the two trp codons. While it is stalled, the ribosome physically shields sequence 1 of the transcript, thus preventing it from forming the 1-2 secondary structure. Sequence 2 is then free to hybridize with sequence 3 to form the 2-3 structure, which then prevents the formation of the 3-4 termination hairpin. RNA polymerase is free to continue transcribing the entire operon. If tryptophan levels in the cell are high, the ribosome will translate the entire leader peptide without interruption and will only stall during translation termination at the stop codon. At this point the ribosome physically shields both sequences 1 and 2. Sequences 3 and 4 are thus free to form the 3-4 structure which terminates transcription. The result is that the operon will be transcribed only when tryptophan is unavailable for the ribosome, while the trpL transcript is constitutively expressed. To ensure that the ribosome binds and begins translation of the leader transcript immediately following its synthesis, a pause site exists in the trpL sequence. Upon reaching this site, RNA polymerase pauses transcription and apparently waits for translation to begin. This mechanism allows for synchronization of transcription and translation, a key element in attenuation.
Sources: en.wikipedia.org
== Pharmacology in pain == Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. It is an essential defensive function where pain works as an alarm to avoid or limit tissue damage. Its neurobiology is complex, and involves stimulation of several different types of nerves. Opioids act upon opioid receptors that are coupled to inhibitor G protein coupled receptors (GPCR). These receptors fall into 3 classes: μ (mu), δ (delta), and κ (kappa) receptors. More than 70% of opioid receptors are μ receptors, predominantly located on the central terminals of nociceptors in the dorsal horn of the spinal cord. The remaining 30% of opioid receptors are located post-synaptically on dendrites of second-order spinothalamic neurons & interneurons. When an opiate binds as an agonist to the GPCR, there will be a signaling cascade resulting in the inhibition of adenylate cyclase and calcium ion channels with the stimulation of potassium ion channels. The net effect of these changes is a reduced intracellular cAMP and hyperpolarization of the neuronal cell reducing neurotransmitter release. Through this pathway, when opiates bind to and activate the mu receptor, there is a decrease transmission of pain signalling. This pathway targeted for the analgesia properties that opiates are known and used for. Other clinically important roles of mu are its involvement in respiratory and cardiovascular functions, gastrointestinal peristalsis, feeding, and mood.
== Properties == Like other biomaterials, resilin is a hydrogel, meaning it is swollen with water. The water content of resilin at neutral pH is 50–60%, and the absence of this water will make a big difference on the material's property: while the hydrated resilin behaves like a rubber, the dehydrated resilin has the properties of a glassy polymer. However, dehydrated resilin is able to return to its rubbery state if water is available. Water serves as a plasticizer in resilin network by increasing the amount of hydrogen bonds. The high concentration of proline and glycine, polyproline helices, and hydrophilic portions all serves to increase water content in resilin protein network. The increase in hydrogen bonds lead to an increase in chain mobility, thus decreases glass transition temperature. The more water content is in resilin network, the less stiff and more resilient the material is. Dehydrated resilin behaves as a glass polymer with low stiffness, strain, and resilience, but a relatively high compressible modulus and glass transition temperature. Rubber like proteins, such as resilin and elastin, are characterized based on their high resilience, low stiffness, and large strain. A high resilience indicate that a sufficient amount of energy input can be stored in the material, and released afterwards. An example of energy input is to stretch the material. Natural resilin (hydrated) has a resilience of 92%, which means it can store 92% of the energy input for release during unloading, indicating a very efficient energy transfer.
Ortner's syndrome is a rare cardiovocal syndrome and involves recurrent laryngeal nerve palsy from cardiovascular disease. It was first described by Norbert Ortner (1865–1935), an Austrian physician, in 1897. Dysphagia caused by a similar mechanism is referred to as dysphagia aortica (also called dysphagia megalatriensis), or, in the case of subclavian artery aberrancy, as dysphagia lusoria. Due to compression of the recurrent laryngeal nerve, it can cause the hoarseness of the voice, which can also be a sign of mitral stenosis. A second Ortner's syndrome, Ortner's syndrome II, refers to abdominal angina.
In February 2018, logistics mismanagement by DHL, which had been selected by KFC UK as their new delivery partner, caused a chicken shortage in the United Kingdom – KFC's largest market in Europe – forcing the company to temporarily close hundreds of restaurants around the country. KFC apologized by taking out adverts in British newspapers showing the company's initials rearranged to read "FCK", followed by an apology, which was well received. In November 2021, Finland's first KFC restaurant was opened at the Itis shopping center in Itäkeskus, Helsinki. A few days before the opening day, a tent had appeared in front of the restaurant, where a man who had kept his identity secret for a few days had stayed, and who on the opening day revealed himself to the public as a vegan activist defending animal rights. After trying to give his speech to those present, the security company carried him away. Even before the opening of the restaurant, in October, news of a controversy over the procurement of a broiler for food from Poland; the cause is mainly related to the risk of salmonella in broilers, which is a significant problem in Poland, whereas its prevalence in Finland is low. Following the 2022 Russian invasion of Ukraine, a number of companies have faced growing pressure to halt operations in Russia but have not yet done so. This includes KFC, which has over 1,000 outlets in Russia, more than any other Western fast food chain. However, within a few years, all Russian KFC restaurants were rebranded as "Rostic's".
Sources: en.wikipedia.org
It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.
The C20 fatty diacid promotes tight binding to serum albumin. That binding reduces renal clearance and extends circulation time compared with an unmodified peptide of similar length.
It is not fully established. Studies indicate that both receptors contribute to the observed effects, but the exact split between the two signaling pathways in humans remains an open question.
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.